Armotraz 1mg Tablet

Armotraz 1mg Tablet is used in the treatment of breast cancer in postmenopausal women. It contains Anastrozole as an active ingredient. It is in a class of drugs called aromatase inhibitors that work by lowering the amount of estrogen that the body makes.

Uses of Armotraz 1mg Tablet

• Breast Cancer

How does Armotraz 1mg Tablet work?

Anastrozole is an aromatase inhibitor. This means that it blocks the body from making estrogen (a hormone). It reduces estrogen levels, which helps to slow or stop the growth of estrogen-dependent breast cancer cells.

How to Use & Dosage

1 mg tablet once a day. May be taken with or without food. Long term use is generally recommended according to the patient’s response and treatment plan.

Possible Side Effects

• Hot flashes
• Joint pain
• Weakness
• Fatigue
• Nausea
• Bone thinning
• Headache
• Rash
• Swelling

Safety Advise

🫀 Liver

Anastrozole may cause changes in liver enzymes. Liver function should be monitored periodically. Please consult your health care provider.

🫘 Kidney

Anastrozole can cause changes in kidney impairment, and kidney function should be checked regularly. Discuss with your health care provider.

🤰 Pregnancy

Armotraz tablets are known to cause harm to the growing fetus when used during pregnancy. Consult with your health care provider.

🤱 Breastfeeding

Do not take Armotraz tablets if you are breast-feeding. The data suggest the drug may pose risks to the fetus. Please talk to your healthcare provider.

🍺 Alcohol

It is unknown whether it is safe to take Armotraz tablets with alcohol. Please talk to your doctor.

Storage Instructions

Store at room temperature (25°C [77°F]). Store the tablets in a dry place, away from excessive moisture.

References

• AstraZeneca Pharmaceuticals LP. ARIMIDEX (Anastrozole) Tablets: Highlights of Prescribing Information. U.S. Food and Drug Administration.
• Baum M, Buzdar A, Cuzick J, et al. Anastrozole Alone or in Combination with Tamoxifen versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early-Stage Breast Cancer: Results of the ATAC Trial. The Lancet. 2002;359(9324):2131-2139.
• Buzdar AU, Jonat W, Howell A, et al. Anastrozole versus Megestrol Acetate in the Treatment of Postmenopausal Women with Advanced Breast Cancer. Journal of Clinical Oncology. 1996;14(7):2000-2011.
• Brunton LL, Knollmann BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. New York: McGraw-Hill Education.
• Tripathi KD. Essentials of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers.

Disclaimer

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.

Manufacturer Details

Name: Cipla Ltd

Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Country of origin: India